Skip to content

Feasibility of the Lee Silverman Voice Treatment®-BIG Intervention in Stroke

Feasibility of the Lee Silverman Voice Treatment®-BIG Intervention in Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03602443
Enrollment
5
Registered
2018-07-26
Start date
2018-08-06
Completion date
2019-12-31
Last updated
2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Stroke

Keywords

Upper Extremity Hemiparesis

Brief summary

Evaluate feasibility (acceptability, subject recruitment/retention, willingness to be randomized, and adherence rates) of delivering the Lee Silverman Voice Treatment®-BIG (LSVT®BIG) intervention with individuals with chronic stroke. Evaluate preliminary effect of the LSVT®BIG intervention on motor function and occupational performance with individuals with chronic stroke.

Detailed description

Literature suggests the Lee Silverman Voice Treatment®-BIG (LSVT-BIG®) program is an effective intervention for individuals with Parkinson's Disease (Ebersbach et al., 2015); however, no literature or research exists on the use of this program as an intervention for individuals with stroke. Therefore, this project aims to measure the effectiveness of the LSVT®BIG program with one individual with a stroke to determine if LSVT®BIG is a feasible and effective occupational therapy intervention for this population. The LSVT®BIG program is an intensive program with hands-on treatment sessions 4 days per week for 4 weeks. Clients complete home exercises every day that enhance the hands-on treatment and help promote carry-over of skills learned to daily tasks. The investigators have completed two case studies with clients with chronic stroke who demonstrated improved outcomes in upper extremity motor function and occupational performance. The purpose of this study is to test the LSVT®BIG intervention with a larger clinical population and to demonstrate that LSVT®BIG is an effective and feasible treatment option for improvement in occupational performance and upper extremity motor function with individuals with stroke.

Interventions

BEHAVIORALLSVT®BIG Intervention

Participants will complete LSVT®BIG intervention which consists of 16 one-hour sessions on 4 consecutive days for 4 weeks, and a home program component.

BEHAVIORALWaitlist Control

Participants randomized to this arm will be followed for the 4-week time period. We will track engagement in any daily exercise (not therapy services) through self-report.

Sponsors

American Occupational Therapy Foundation
CollaboratorOTHER
University of Missouri-Columbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

The study is a randomized, wait-list, cross-over design pilot feasibility trial.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age 18 or older 2. Diagnosis of first-ever ischemic stroke at least 6 months prior as confirmed by medical records 3. Has more than a moderate stroke (NIH Stroke Scale \> 20) 4. Can read and write English. To ensure participants can understand instructions in clinic and home exercise sessions

Exclusion criteria

1. More than moderate motor deficits (Fugl-Meyer UE Assessment \< 32/66) 2. More than mild cognitive impairment (Mini-Mental Status Examination \< 24) 3. More than mild balance deficits (Berg Balance Scale \<45) 4. Minimal or no impairments from their stroke (NIH Stroke Scale \< 6) 5. Currently receiving occupational therapy or physical therapy services 6. Has had more than one stroke

Design outcomes

Primary

MeasureTime frameDescription
Adherence Rate1 yearFor each study participant, an percentage of clinic visits and home exercises completed will be calculated. Rates will be averaged within groups.

Secondary

MeasureTime frameDescription
Change from baseline in Canadian Occupational Performance Measure (COPM)4 weeksThe Canadian occupational Performance Measure is a measure of the subject's self-rated performance and satisfaction of their performance with 5 self-identified areas of occupation/activities.
Change from baseline in Performance Assessment of Self-Care Skills (PASS)4 weeksThe Performance Assessment of Self-Care Skills (PASS) assesses basic self-care and instrumental activities of daily living. Subscales: Independence, Safety, Adequacy (minimum: 0, maximum: 3). There is no total score reported.
Change from baseline in PROMIS-434 weeksGeneral assessment of quality of life and participation in daily life. Assessment is from the standardized NIH Toolbox. T-scores are reported on scale of 0-100 (50 is average).
Change from baseline in Modified Ashworth Scale (MAS)4 weeksAssess muscle tone of various joints. Only joints with any spasticity will be recorded. Scale ranges from 0 (no spasticity) to 3 (rigid joint).
Change from baseline in Wolf Motor Function Test (WMFT)4 weeksAssessment of upper extremity motor function.
Change from baseline in Upper Extremity Strength4 weeksUpper extremity strength will be assessed through Manual Muscle Testing.
Retention Rate1 yearRate: Number of study participants completing the study relative to the number initially enrolled in the study
Recruitment Rate1 yearA log of calls will be kept. The number of screened study participants relative to the total number of calls made will be used to calculate recruitment rate.
Change from baseline in Upper Extremity Range of Motion4 weeksAngle (degrees) of the upper extremities as measured by a goniometer.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026